Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in United StatesA Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy
- Where
- Houston
- Age
- 18 years and over
- People
- 250
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07856719 - Phase 1Taking peopleUsing Silverlon® for Head and Neck Patients With Tracheostomies
- Where
- Syracuse
- Age
- 18 years and over
- People
- 10
- Run by
- State University of New York - Upstate Medical University
See details and how to joinNCT07856732 - Phase 4Taking peopleIntraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
- Where
- Portland
- Age
- 18 years to 89 years
- People
- 58
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07857655 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 2Taking peopleComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT06265285 - No phaseNot yet taking people in United StatesSpeed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer Survivors
- Where
- Birmingham
- Age
- 18 years to 89 years
- People
- 30
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07740616 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Austin, Baltimore, Boston, Celebration, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, East Brunswick, Gainesville, Hackensack, Hershey, Indianapolis, Irving, Jacksonville, Las Vegas, Littleton, Louisville, Miami, Milwaukee, Myrtle Beach, Nashville, Newark, New Haven, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Plano, Plantation, Portland, Rochester, Santa Barbara, Syracuse, Tampa, Tucson, Tyler
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 2Taking peopleDe-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 18 years and over
- People
- 455
- Run by
- Mayo Clinic
See details and how to joinNCT05541016 - Phase 1/2Taking people177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Where
- Dothan, Grand Rapids, Houston, Omaha
- Age
- 18 years and over
- People
- 61
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871 - No phaseNot yet taking people in United StatesUnderstanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
- Where
- Houston
- Age
- 18 years to 100 years
- People
- 94
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07852949 - Phase 3Taking peopleA Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- Where
- Albuquerque, Ann Arbor, Aurora, Austin, Baltimore, Baton Rouge, Bethesda, Birmingham, Boston, Charlotte, Cleveland, Colorado Springs, Columbia, Dallas, Des Moines, East Brunswick, Fairfax, Fairhaven, Flower Mound, Fort Myers, Fountain Valley, Fullerton, Gainesville, Hackensack, Houston, Hyattsville, Kansas City, Lone Tree, Los Angeles, Louisville, Miami, Minneapolis, Nashville, New Brunswick, New York, Niles, Norfolk, Odessa, Orange, Palm Bay, Philadelphia, Phoenix, Pittsburgh, Portland, Prescott Valley, Richmond, Salt Lake City, Santa Rosa, Shreveport, Sioux Falls, Spokane, Springdale, St Louis, Stony Brook, Tacoma, Towson, Tyler, Upper Marlboro, Washington D.C., West Jordan, West Palm Beach, Whittier, Winston-Salem, York
- Age
- 18 years to 130 years
- People
- 1,145 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06129864 - Phase 1Taking peopleA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Where
- Columbus, Fairfax, Farmington Hills, Grand Rapids, Houston, La Jolla, Morristown, Portland, Santa Monica, Spokane, Tampa, West Valley City
- Age
- 18 years and over
- People
- 170
- Run by
- ALX Oncology Inc.
See details and how to joinNCT07085091 - Phase 1Taking peopleA Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Where
- Fairfax, Maumee, Portland
- Age
- 18 years and over
- People
- 74
- Run by
- TwoStep Therapeutics, Inc.
See details and how to joinNCT07814248 - No phaseTaking peopleOnline Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck Surgery
- Where
- St Louis
- Age
- 18 years and over
- People
- 50
- Run by
- Washington University School of Medicine
See details and how to joinNCT07848841 - Phase 1Taking peopleA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Where
- Boston, Charlotte, Duarte, Gilbert, Houston, Jacksonville, Los Angeles, Miami, Milwaukee, Nashville, New Brunswick, Newport Beach, New York, Pittsburgh, Portland, Round Rock, Santa Monica, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 45
- Run by
- AstraZeneca
See details and how to joinNCT05877599 - No phaseTaking peopleDose Adjusted Chemoradiotherapy in HPV-Associated Oropharynx Cancer of the Elderly
- Where
- Jacksonville
- Age
- 65 years to 99 years
- People
- 20
- Run by
- Omar Mahmoud
See details and how to joinNCT06309225 - No phaseTaking peoplePilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
- Where
- Houston
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06667427 - No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - No phaseNot yet taking people in United StatesEvaluating Avive+ Soft Tissue Matrix for Prevention of Superficial Radial Nerve Morbidity Following Radial Forearm Free Flap Harvest
- Where
- Birmingham
- Age
- 18 years and over
- People
- 80
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07558096 - No phaseNot yet taking people in United StatesFeasibility and Validation of an Automated AI-Enabled Deep Ultraviolet (DUV) Cytology Platform for Point-of-Care Oral Cancer Triage
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 270
- Run by
- Anh Le
See details and how to joinNCT07842211 - Phase 1/2Taking peopleSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Where
- Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
- Age
- 18 years and over
- People
- 134
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06047379 - Phase 3Taking peopleA Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
- Where
- Basking Ridge, Commack, Harrison, Hartford, Miami, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 291
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06563479 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - No phaseTaking peopleBiomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
- Where
- Omaha, Pittsburgh, Tampa
- Age
- 18 years and over
- People
- 400
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06305676 - Phase 1Taking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Aurora, Beverly Hills, Boston, Chicago, Duarte, Fairfax, Greenville, Houston, Iowa City, Louisville, Miami, Nashville, New Haven, New York, Orange, Orlando, Port Saint Lucie, Santa Monica, Seattle, Washington D.C.
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432